{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:50:21Z","timestamp":1788094221444,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["150937\/2022-9"],"award-info":[{"award-number":["150937\/2022-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/13877-1"],"award-info":[{"award-number":["2018\/13877-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/12876-7"],"award-info":[{"award-number":["2022\/12876-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/08582-5"],"award-info":[{"award-number":["2019\/08582-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["BR 10 2024 016016 9"],"award-info":[{"award-number":["BR 10 2024 016016 9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejpb.2024.114533","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T10:43:35Z","timestamp":1728989015000},"page":"114533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: Development, characterization and cell-based investigation"],"prefix":"10.1016","volume":"205","author":[{"given":"Regina","family":"Gomes Dar\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Beatriz Chieco Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Silva Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana B.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114533_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009337","article-title":"Wound repair and regeneration: mechanisms, signaling, and translation","volume":"6","author":"Eming","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejpb.2024.114533_b0010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1524-475X.2009.00543.x","article-title":"Human skin wounds: A major and snowballing threat to public health and the economy: perspective article","volume":"17","author":"Sen","year":"2009","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.ejpb.2024.114533_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jval.2017.07.007","article-title":"An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds","volume":"21","author":"Nussbaum","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.ejpb.2024.114533_b0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/wound.2017.0761","article-title":"Immune regulation of skin wound healing: Mechanisms and novel therapeutic targets","volume":"7","author":"Larouche","year":"2018","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"10.1016\/j.ejpb.2024.114533_b0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1089\/wound.2020.1254","article-title":"Limited treatment options for diabetic wounds: barriers to clinical translation despite therapeutic success in murine models","volume":"10","author":"Barakat","year":"2021","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"10.1016\/j.ejpb.2024.114533_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2024.114533_b0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejpb.2024.114533_b0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2024.114533_b0045","doi-asserted-by":"crossref","unstructured":". Bellosta, D. Via, M. Canavesi, P. Pfister, R. Fumagalli, R. Paoletti, F. Bernini, HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages, 1998. http:\/\/www.atvbaha.org.","DOI":"10.1161\/01.ATV.18.11.1671"},{"key":"10.1016\/j.ejpb.2024.114533_b0050","article-title":"A Novel Anti-inflammatory role for simvastatin","volume":"1","author":"Leung","year":"2003","journal-title":"Inflammatory Arthritis"},{"key":"10.1016\/j.ejpb.2024.114533_b0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejpb.2024.114533_b0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium-dependent effects of statins","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejpb.2024.114533_b0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbrc.2009.07.057","article-title":"Statins and angiogenesis: is it about connections?","volume":"387","author":"Khaidakov","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2024.114533_b0070","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-4632.2010.04579.x","article-title":"Statins in dermatology","volume":"49","author":"Jowkar","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejpb.2024.114533_b0075","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.ajpath.2012.08.023","article-title":"Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis","volume":"181","author":"Asai","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2024.114533_b0080","article-title":"Topical simvastatin enhances tissue regeneration in full-thickness skin wounds","author":"Khoshneviszadeh","year":"2014","journal-title":"Rat. Models"},{"key":"10.1016\/j.ejpb.2024.114533_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213658","article-title":"Co-delivery of simvastatin and microRNA-21 through liposome could accelerates the wound healing process","volume":"154","author":"Kiani","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.ejpb.2024.114533_b0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/exd.12474","article-title":"Targeting adenosine receptors to prevent inflammatory skin diseases","volume":"23","author":"Gessi","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejpb.2024.114533_b0095","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bcp.2008.11.002","article-title":"Adenosine receptor agonists for promotion of dermal wound healing","volume":"77","author":"Valls","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114533_b0100","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2174\/1381612825666190716145206","article-title":"Role and function of adenosine and its receptors in inflammation, neuroinflammation, IBS, autoimmune inflammatory disorders, rheumatoid arthritis and psoriasis","volume":"25","author":"Shakya","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2024.114533_b0105","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.2147\/IJN.S372211","article-title":"Nanobiotechnology: applications in chronic wound healing","volume":"17","author":"Jiang","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2024.114533_b0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ijbiomac.2021.04.168","article-title":"Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing","volume":"183","author":"Costa-Fernandez","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2024.114533_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105296","article-title":"Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole","volume":"149","author":"Passos","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114533_b0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114533_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119336","article-title":"Evaluation of lipid nanoparticles for topical delivery of protocatechuic acid and ethyl protocatechuate as a new photoprotection strategy","volume":"582","author":"Dar\u00e9","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114533_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2012.06.024","article-title":"Objective assessment of nanoparticle disposition in mammalian skin after topical exposure","volume":"162","author":"Campbell","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114533_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118484","article-title":"Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies","volume":"569","author":"Vairo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114533_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114533_b0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","article-title":"Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)","volume":"70","author":"Fang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114533_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","article-title":"Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system","volume":"45","author":"Hu","year":"2005","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/j.ejpb.2024.114533_b0155","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/10837450.2013.778872","article-title":"Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam","volume":"19","author":"Khalil","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2024.114533_b0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jddst.2019.04.019","article-title":"Improved in vivo performance and immunomodulatory effect of novel Omega-3 fatty acid based tacrolimus nanostructured lipid carrier","volume":"52","author":"Khan","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2024.114533_b0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/02652040600612439","article-title":"Polymorphic behavior of Compritol\u00ae888 ATO as bulk lipid and as SLN and NLC","volume":"23","author":"Souto","year":"2006","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2024.114533_b0170","unstructured":"ICH, international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised tripartite guideline stability testing of new drug substances and products Q1A(R2), 2003. https:\/\/database.ich.org\/sites\/default\/files\/Q1A%28R2%29%20Guideline.pdf (accessed May 23, 2024)."},{"key":"10.1016\/j.ejpb.2024.114533_b0175","article-title":"Rapid colorimetric assay for cellular growth and survival","author":"Mosmann","year":"1983","journal-title":"Appl. Proliferation Cytotoxicity Assays"},{"key":"10.1016\/j.ejpb.2024.114533_b0180","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2024.114533_b0185","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4161\/cam.36224","article-title":"An introduction to the wound healing assay using live-cell microscopy","volume":"8","author":"Jonkman","year":"2014","journal-title":"Cell Adh. Migr."},{"key":"10.1016\/j.ejpb.2024.114533_b0190","article-title":"Optimized scratch assay for in vitro testing of cell migration with an automated optical camera","volume":"2018","author":"Vang Mouritzen","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejpb.2024.114533_b0195","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1208\/s12249-016-0643-7","article-title":"Potential of non-aqueous microemulsions to improve the delivery of lipophilic drugs to the skin","volume":"18","author":"Carvalho","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2024.114533_b0200","first-page":"207","article-title":"Histological and functional comparisons of four anatomical regions of porcine skin with human abdominal skin","volume":"48","author":"Khiao In","year":"2019","journal-title":"J. Veterinary Med. Series C: Anatomia Histologia Embryologia"},{"issue":"33","key":"10.1016\/j.ejpb.2024.114533_b0205","article-title":"Transdermal permeation of drugs in various animal species","volume":"9","author":"Todo","year":"2017","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejpb.2024.114533_b0210","doi-asserted-by":"crossref","DOI":"10.1023\/B:PHAM.0000036912.94452.d0","article-title":"Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates","volume":"21","author":"Sekkat","year":"2004","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114533_b0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1081\/DCT-100108474","article-title":"In vitro permeability and binding of hydrocarbons in pig ear and human abdominal skin","volume":"25","author":"Singh","year":"2002","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.ejpb.2024.114533_b0220","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ijbiomac.2017.04.094","article-title":"Monoolein-alginate beads as a platform to promote adenosine cutaneous localization and wound healing","volume":"102","author":"Ng","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2024.114533_b0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2011.05.044","article-title":"Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake","volume":"415","author":"Tiwari","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114533_b0230","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005486.pub2","article-title":"Topical silver for treating infected wounds","author":"Vermeulen","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejpb.2024.114533_b0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.addr.2018.09.010","article-title":"Therapeutic strategies for enhancing angiogenesis in wound healing","volume":"146","author":"Veith","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2024.114533_b0240","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114533_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox12030633","article-title":"Solid lipid nanoparticles: review of the current research on encapsulation and delivery systems for active and antioxidant compounds","volume":"12","author":"Subroto","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2024.114533_b0250","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.colsurfb.2015.12.033","article-title":"Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique","volume":"140","author":"Becker Peres","year":"2016","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/j.ejpb.2024.114533_b0255","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2024.114533_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/750891","article-title":"Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery","volume":"2012","author":"Severino","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114533_b0265","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/03639045.2019.1569023","article-title":"Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations","volume":"45","author":"Jansook","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2024.114533_b0270","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.xphs.2021.04.012","article-title":"The effects of solid and liquid lipids on the physicochemical properties of nanostructured lipid carriers","volume":"110","author":"Apostolou","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114533_b0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15171\/apb.2016.021","article-title":"The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers a comparative literature review","volume":"6","author":"Bahari","year":"2016","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2024.114533_b0280","unstructured":"PubChem, National Center for Biotechnology Information. PubChem Compound Summary for CID 3033877, 2,3-Dihydroxypropyl octanoate., (2024). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/2_3-Dihydroxypropyl-octanoate (accessed May 22, 2024)."},{"key":"10.1016\/j.ejpb.2024.114533_b0285","unstructured":"Cremer, Safety Data Sheet: Miglyol 810 N., Cremer Oleo Division Version: 1 (2012) 1\u20137. https:\/\/www.haenseler.ch\/userdata\/custom_files\/security_sheet\/29305000_EN.pdf (accessed May 22, 2024)."},{"key":"10.1016\/j.ejpb.2024.114533_b0290","unstructured":"W. Mehnert, K. Mader, Solid lipid nanoparticles Production, characterization and applications, 2001. www.elsevier.com\/locate\/drugdeliv."},{"key":"10.1016\/j.ejpb.2024.114533_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.113734","article-title":"Impact of liquid lipid on development and stability of trimyristin nanostructured lipid carriers for oral delivery of resveratrol","volume":"316","author":"Houacine","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2024.114533_b0300","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1039\/D1TB02297K","article-title":"Evaluating the impact of systematic hydrophobic modification of model drugs on the control, stability and loading of lipid-based nanoparticles","volume":"9","author":"Hogarth","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2024.114533_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/jfb14070374","article-title":"Solid lipid-polymer hybrid nanoplatform for topical delivery of siRNA. in vitro biological activity and permeation studies","volume":"14","author":"de Araujo","year":"2023","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.ejpb.2024.114533_b0310","article-title":"Synergistic effect of topically delivered strontium ions and simvastatin through alginate diamine PEG-g-poly (PEGMA) xerogels for wound healing under high glucose mediated inflammatory conditions: In vitro evaluations","volume":"89","author":"Rajalekshmy","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2024.114533_b0315","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-022-00226-6","article-title":"Accelerating skin regeneration and wound healing by controlled ROS from photodynamic treatment","volume":"42","author":"Khorsandi","year":"2022","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.ejpb.2024.114533_b0320","first-page":"39","article-title":"Differential scanning calorimetry: An invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions","author":"Chiu","year":"2011","journal-title":"J. Pharm. Bioallied. Sci."},{"key":"10.1016\/j.ejpb.2024.114533_b0325","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tca.2005.09.011","article-title":"Physicochemical studies on solid dispersions of poorly water-soluble drugs: Evaluation of capabilities and limitations of thermal analysis techniques","volume":"439","author":"Bikiaris","year":"2005","journal-title":"Thermochim Acta"},{"key":"10.1016\/j.ejpb.2024.114533_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2005.07.014","article-title":"Skin permeation: the years of enlightenment","author":"Hadgraft","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114533_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106873","article-title":"In vitro permeation testing for the evaluation of drug delivery to the skin","volume":"201","author":"Lane","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114533_b0340","doi-asserted-by":"crossref","unstructured":"R.H. Muller, K. Mader, S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art, (2000) 161\u2013177. www.elsevier.com\/locate\/ejphabio.","DOI":"10.1016\/S0939-6411(00)00087-4"},{"key":"10.1016\/j.ejpb.2024.114533_b0345","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.2147\/IJN.S73010","article-title":"Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia","volume":"9","author":"Shamma","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2024.114533_b0350","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2015.05.005","article-title":"Cutaneous penetration of soft nanoparticles via photodamaged skin: Lipid-based and polymer-based nanocarriers for drug delivery","volume":"94","author":"Hung","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112400359X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112400359X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T23:33:03Z","timestamp":1733009583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112400359X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":70,"alternative-id":["S093964112400359X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114533","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: Development, characterization and cell-based investigation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114533"}}